Bank of Montreal Can Has $272,000 Holdings in AdaptHealth Corp. (NASDAQ:AHCO)

Bank of Montreal Can boosted its holdings in AdaptHealth Corp. (NASDAQ:AHCO) by 13.1% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 28,558 shares of the company’s stock after purchasing an additional 3,299 shares during the quarter. Bank of Montreal Can’s holdings in AdaptHealth were worth $272,000 at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. Assetmark Inc. acquired a new stake in shares of AdaptHealth in the fourth quarter valued at approximately $28,000. Blue Trust Inc. raised its holdings in AdaptHealth by 24.1% in the 4th quarter. Blue Trust Inc. now owns 5,746 shares of the company’s stock valued at $55,000 after acquiring an additional 1,115 shares in the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management lifted its position in shares of AdaptHealth by 15.4% during the 4th quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 12,663 shares of the company’s stock valued at $121,000 after acquiring an additional 1,690 shares during the period. KLP Kapitalforvaltning AS acquired a new stake in shares of AdaptHealth during the 4th quarter worth $169,000. Finally, Proficio Capital Partners LLC bought a new position in shares of AdaptHealth in the fourth quarter worth $181,000. Institutional investors own 82.67% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts recently weighed in on AHCO shares. Royal Bank of Canada upped their price objective on shares of AdaptHealth from $11.00 to $14.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 26th. Canaccord Genuity Group increased their price target on shares of AdaptHealth from $13.00 to $14.00 and gave the stock a “buy” rating in a research report on Wednesday, February 26th. UBS Group decreased their price objective on shares of AdaptHealth from $12.00 to $11.00 and set a “buy” rating on the stock in a research note on Thursday, February 13th. Robert W. Baird upped their target price on AdaptHealth from $14.00 to $16.00 and gave the stock an “outperform” rating in a research note on Thursday, February 27th. Finally, Truist Financial lifted their price target on AdaptHealth from $12.00 to $14.00 and gave the company a “buy” rating in a research note on Wednesday, February 26th. Five equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company presently has an average rating of “Buy” and an average target price of $13.80.

AdaptHealth Stock Performance

Shares of AdaptHealth stock opened at $8.03 on Friday. The company’s 50 day moving average price is $9.60 and its two-hundred day moving average price is $9.89. The firm has a market capitalization of $1.08 billion, a P/E ratio of -4.87, a P/E/G ratio of 1.08 and a beta of 1.44. The company has a debt-to-equity ratio of 1.34, a current ratio of 1.24 and a quick ratio of 1.00. AdaptHealth Corp. has a fifty-two week low of $7.11 and a fifty-two week high of $11.90.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.